Page last updated: 2024-08-24

triazoles and Body Weight

triazoles has been researched along with Body Weight in 213 studies

Research

Studies (213)

TimeframeStudies, this research(%)All Research%
pre-199023 (10.80)18.7374
1990's18 (8.45)18.2507
2000's58 (27.23)29.6817
2010's108 (50.70)24.3611
2020's6 (2.82)2.80

Authors

AuthorsStudies
Ari, C; Brunner, B; D'Agostino, DP; Kovács, Z1
Khokhlov, AL; Leykin, ZN1
Adrian, TE; Albawardi, A; Almarzooqi, S; Haneefa, S; Hennig, R; Imbaraj, E; Maruta, H; Nemmar, A; Subramanya, S; Zaaba, NE1
Bouslama, R; Chi, NW; Dumont, V; Krauss, S; Kuusela, S; Lehtonen, S; Linden, AM; Pirinen, E; Ramadan, UA; Rinnankoski-Tuikka, R; Waaler, J; Wang, H1
Alenina, N; Bader, M; Dias-Júnior, NM; Eleutério-Silva, MA; Ferreira-Neves, VP; Moura, FA; Nunes-Souza, V; Rabelo, LA1
Bernardo, V; Fernandez, AJ; Liverman, R; Miles, A; Tippett, A; Yildirim, I1
Ambhore, SR; Goyal, VK; Londhe, S; Nakka, H; Nirogi, R; Pandey, SK1
Benrick, A; Carlström, M; Cushman, SW; Fornes, R; Hu, M; Ivarsson, N; Maciel, GAR; Maliqueo, M; Marcondes, RR; Stener-Victorin, E; Stenkula, KG1
Afsar, T; Almajwal, A; Jahan, S; Pirzada, M; Rauf, N; Razak, S; Ullah, A; Ullah, H1
Camerino, GM; Cantatore, P; Conte, E; Cormio, A; Fehrentz, JA; Fonzino, A; Fracasso, F; Lezza, AMS; Liantonio, A; Martinez, J; Musicco, C; Pesce, V; Rizzi, L; Sirago, G; Torsello, A1
Abdo, M; Fekry, E; Makary, S1
Malik, S; Mellon, PL; Ryan, GE1
Ahn, JH; Chen, BH; Hwang, IK; Kang, IJ; Kim, DW; Kim, H; Kim, YM; Lee, CH; Lee, JC; Lee, TK; Park, JH; Song, M; Won, MH; Yan, BC1
Boudawara, T; Chaâbane, M; Chelly, S; Ellouze Chaabouni, S; Elwej, A; Ghorbel, I; Mnif, H; Soudani, N; Zeghal, N1
Abid, A; Afsar, T; Almajwal, A; Jahan, S; Khalid, S; Razak, S; Shaheen, G1
Ding, J; Ge, LQ; Wu, JC; Xu, B; Yang, GQ; Zhang, X1
Charalambous, C; Havlickova, T; Jerabek, P; Lapka, M; Puskina, N; Sustkova-Fiserova, M1
Fukui, K; Nangaku, M; Saito, H; Sugahara, M; Tanaka, S; Tanaka, T; Wakashima, T1
Feng, WY; Hu, L; Huang, L; Li, TF; Liu, XM; Luo, XX; Ma, XL; Wu, CF1
Bartola, LD; Giampietro, C; Giampietro, O; Masoni, MC; Matteucci, E1
Badole, SL; Bagul, PP; Coutinho, EC; Ghule, AE; Jangam, GB; Joshi, AC; Khedkar, VM; Khose, RD; Mahamuni, SP; Raut, CG1
Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Pintana, H1
Bhargava, A; Del Prato, S; Dharmalingam, M; Garber, AJ; Philis-Tsimikas, A; Rasmussen, S; Satman, I; Skjøth, TV1
Caderni, G; Femia, AP; Lodovici, M; Maglieri, G; Mannucci, E; Raimondi, L1
Dahooee Balooch, F; Ebrahimpour, R; Fatemi, SJ; Iranmanesh, M1
Charbonnel, B; Dejager, S; Schweizer, A1
Scheen, AJ1
Han, J; Malloy, J; Meloni, A1
Du, Q; Liang, YY; Wang, YJ; Wu, B; Yang, S; Zhao, YY1
Epstein, S; Gallagher, EJ; Kornhauser, C; LeRoith, D; Sun, H; Tobin-Hess, A; Yakar, S1
Badole, SL; Bagul, PP; Chaudhari, SM; Joshi, AC; Khose, RD; Mahamuni, SP; Raut, CG; Zanwar, AA1
Canovatchel, W; Davidson, J; Januszewicz, A; Lavalle-González, FJ; Meininger, G; Qiu, R; Tong, C1
Chang, G; Duan, Q; Lu, K; Qin, S; Wang, Y; Ye, L; Zhang, D; Zhang, P; Zheng, A1
Ajimi, S; Aso, S; Furukawa, K; Hasegawa, R; Hoshuyama, S; Kikuchi, J; Koga, T; Kusune, Y; Miyata, K; Yoshida, T1
Alba, M; Canovatchel, W; Cefalu, WT; Edwards, R; Jodar, E; Kim, KA; Meininger, G; Stenlöf, K; Tong, C1
Hardy, E; Jabbour, SA; Parikh, S; Sugg, J1
Andersén, H; Bohlooly-Y, M; Cottrell, EC; Denn, M; DeSchoolmeester, J; Goldberg, FW; Gutierrez, PM; Harno, E; Leighton, B; Swales, JG; Turnbull, AV; White, A; Wild, MJ; Yu, A1
Beckman, DA; DeCristofaro, M; Pouliot, L; Samadfam, R; Schneider, M; Smith, SY1
Gallacher, DJ; Hemmeryckx, B; Roger Lijnen, H; Rong Lu, H; Swinnen, M1
Cunningham, C; Dey, M; Forest, T; Frederick, C; Holder, D; Prahalada, S; Smith, A; Yao, X1
Schnell, O1
Belden, JB; Hartman, EA; McMurry, ST; Smith, LM1
Coric, J; Dizdarevic-Bostandzic, A; Djelilovic-Vranic, J; Izetbegovic, S; Karamehic, J; Macic-Dzankovic, A; Panjeta, M; Velija-Asimi, Z1
Aroor, AR; Garro, M; Habibi, J; Hayden, MR; Johnson, M; Lastra, G; Manrique, C; Meuth, A; Nistala, R; Sowers, JR; Whaley-Connell, A1
Funahashi, T; Hayashi, M; Hibuse, T; Hirata, A; Kashine, S; Kimura, T; Kishida, K; Maeda, N; Minami, T; Nakagawa, Y; Nishizawa, H; Oka, A; Shimomura, I; Takeshita, E1
Ahrén, B; Cirkel, DT; Feinglos, MN; Johnson, SL; Perry, C; Stewart, M; Yang, F1
Gao, Y; Guo, B; Li, J; Li, Y; Liu, C; Lv, X; Wang, H1
Guthrie, R; Slee, A; Traina, S1
Katakami, N; Matsuoka, TA; Shimomura, I; Shiraiwa, T; Takahara, M1
Blayo, AL; Fehrentz, JA; Haluzík, M; Holubová, M; Jurčovičová, J; Lacinová, Z; Maletínská, L; Martinez, J; Moulin, A; Nagelová, V; Stofkova, A; Sýkora, D; Zelezná, B1
Baerts, L; Behets, GJ; D'Haese, PC; De Meester, I; Glorie, L; Verhulst, A1
Gou, Z; Ma, M; Wang, F; Wang, T; Zhai, SD1
Marchesini, G; Melchiorri, D; Montilla, S; Pani, L; Sammarco, A; Siviero, PD; Tomino, C; Trotta, MP1
Bailey, RA; Blonde, L; Meininger, GE; Rupnow, MF; Vijapurkar, U1
Cellai, L; Corti, F; Dettori, I; Melani, A; Pedata, F1
Allshouse, AA; Alvero, R; Casson, PR; Christman, GM; Coutifaris, C; Diamond, MP; Eisenberg, E; Krawetz, SA; Legro, RS; Polotsky, AJ; Santoro, N; Schlaff, WD; Trussell, JC; Zhang, H1
Aratsu, Y; Hamada, H; Ishii, Y; Kakutani, M; Kume, S; Nishiu, J; Oda, T; Ohe, Y; Ohta, T; Okuma, C; Oshida, S; Tadaki, H; Taniuchi, H; Yamanaka, K; Yata, S1
Couriel, DR; Kauffman, CA; Miceli, MH; Perissinotti, AJ1
Birch Petersen, K; la Cour Freiesleben, N; Lauritsen, MP; Pedersen, AT; Pedersen, NG1
Lian, Y; Wang, W; Zhao, F1
Cao, SF; Hu, WL; Jiang, LY; Wu, MM1
Ben Haj Salah, K; Biagini, G; Bresciani, E; Fehrentz, JA; Liantonio, A; Locatelli, V; Martinez, J; Molteni, L; Omeljaniuk, RJ; Ravelli, M; Rizzi, L; Torsello, A1
Mahmood, I1
Chahoud, I; Gericke, C; Grote, K; Haider, W; Herzler, M; Niemann, L; Selzsam, B1
Garcia, PC; Gerardin, DC; Moreira, EG; Pereira, OC; Piffer, RC1
Minobe, Y; Shiraishi, K; Umano, T; Yamasaki, K1
Drucker, DJ; Duez, H; Giacca, A; Lewis, GF; Smith, AC; Szeto, L; Xiao, C1
Davidson, JA; Gross, JL; Parente, EB1
Chen, PJ; Hester, SD; Lambert, GR; Moore, T; Nesnow, S; Padgett, WT; Thai, SF; Winnik, W1
Adamicova, K; Kajo, K; Kubatka, P; Nosalova, G; Ostatnikova, D; Sadlonova, J; Sadlonova, V1
Furukawa, T; Manabe, S; Matsuyama, T; Saitoh, W; Sakurai, K; Sanbuissho, A; Shirai, M; Teranishi, M1
Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH1
Mikhail, N2
Ema, M; Hirata-Koizumi, M; Hirose, A; Kamata, E; Kawabata, M; Matsuno, K; Matsuyama, T; Yajima, K1
De Bock, M; Dobenecker, B; Engelen, M; Goossens, L; Kienzle, E; Scholz, A1
Cognard, E; Shepherd, PR; Smith, GC; Vickers, MH1
Andreu, E; Fernández, C; Ferrando, MD; Sancho, E; Villarroel, MJ1
Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Franzetti, IG; Gadaleta, G; Maffioli, P; Piccinni, MN; Querci, F; Ragonesi, PD; Salvadeo, SA1
Aberdeen, GW; Albrecht, ED; Baschat, AA; Harman, CR; Langenberg, PW; Pepe, GJ; Weiner, CP1
Alexander, CM; Siler, SQ; Topp, BG; Waters, SB1
Birnbaum, Y; Keyes, KT; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C1
Arvapalli, RK; Blough, ER; Gadde, MK; Kakarla, SK; Katta, A; Laurino, JP; Paturi, S; Rice, KM; Walker, EM; Wehner, P; Wu, M1
Bilo, HJ; Goudswaard, AN; Houweling, ST; Kleefstra, N; Kooy, A; van Hateren, KJ; Verhoeven, S1
Lteif, A; Mitre, N1
Bilan, VP; Jackson, EK; Tofovic, DS1
Davies, MJ; Engel, SS; Mavros, P; Radican, L; Rajagopalan, S; Yin, D; Zhang, Q1
Fritzsche, B; Nau, H; Rühl, R; Schmidt, A; Schuchardt, JP; Schweigert, FJ1
Clar, C; Cummins, E; Marien, M; Philip, S; Richter, B; Royle, P; Waugh, N1
Fernandes, R; Ferreira, L; Garrido, P; Mega, C; Melo, A; Nunes, S; Parada, B; Pinto, F; Pinto, R; Reis, F; Santos, P; Sereno, J; Teixeira, F; Teixeira-de-Lemos, E; Vala, H; Velada, I1
Fatemi, SJ; Saljooghi, ASh1
Borelli, MI; Del Zotto, H; Flores, LE; Francini, F; Gagliardino, JJ; Madrid, VG; Maiztegui, B; Massa, ML; Raschia, MA; Rebolledo, OR1
Coben, J; Dobrian, AD; Galkina, EV; Leone, KA; Lindsay, JW; Ma, K; Ma, Q; Nadler, JL1
Borgia, JA; Mufson, EJ; Overk, CR1
Anjana, RM; Kishore, U; Mohan, V; Sudhakaran, C; Unnikrishnan, R1
Best, JH; Garrison, LP; Li, Y; Malloy, J; Peyrot, M; Rubin, RR; Yan, P1
Moore, T; Nesnow, S; Padgett, WT1
Christiaens, V; Lijnen, HR; Scroyen, L1
Chen, B; Ernsberger, P; Escobedo, LV; Hou, D; Koletsky, MS; Koletsky, RJ; Moore, A1
Boor, R; Brandt, C; Jürgens, U; Korn-Merker, E; May, TW; Rambeck, B1
Horie, T; Shitara, Y; Tanii, H1
Boucheron, JA; Brainard, TA; Carballo, LH; Epperly, AH; Fisher, JC; Goetz, AS; Hommel, JD; Ignar, DM; Larkin, AL; Noble, KN; Shearer, TW; Sorensen, SD; Speake, JD; Stroup, AE1
Cander, S; Ersoy, C; Ertürk, E; Gül, CB; Imamoğlu, S; Kırhan, E; Kıyıcı, S; Öz, Ö; Sarandol, E; Sığırlı, D; Tuncel, E; Ünal, OK; Yorulmaz, H1
Böhm, M; Kazakov, A; Laufs, U; Lenski, M; Marx, N1
Atilgan, D; Boztepe, O; Erdemir, F; Markoc, F; Sahin, S; Suha-Parlaktas, B1
Cho, JH; Ham, DS; Kim, ES; Kim, JW; Park, HS; Sun, C; Yeom, JA; Yoon, KH1
Balooch, FD; Fatemi, SJ; Golbafan, MR; Iranmanesh, M; Saljooghi, AS1
de Lemos, ET; Fernandes, R; Mascarenhas-Melo, F; Mega, C; Oliveira, J; Reis, F; Teixeira, F; Vala, H1
Holst, JJ; Liu, MK; Salen, G; Saumoy, M; Shang, Q; Xu, G1
Ahmad, Z; Chung, JH; Kadir, AA; Somchit, N; Yaacob, A; Zakaria, ZA1
Rabasseda, X1
Choi, SH; Hong, ES; Jang, HC; Kang, SM; Khang, AR; Lim, S; Park, KS; Shin, H; Walford, GA; Yoon, JW1
Ahrén, B; Deacon, CF; Mannucci, E1
Allister, EM; Bhattacharjee, A; Wheeler, MB1
Cutillas, B; Hernández-Mir, G; Llorens, J; Saldaña-Ruíz, S; Sedó-Cabezón, L1
Cheetham, S; Francis, J; Kirby, M; Poucher, SM; Vickers, SP; Zinker, B1
Burgmaier, M; Esser, M; Liberman, A; Ludwig, A; Marx, N; Ostertag, R; Vasic, D; Vittone, F; Walcher, D1
Aschner, P; Chan, J; Dain, MP; Echtay, A; Fonseca, V; Owens, DR; Picard, S; Pilorget, V; Wang, E1
Gupta, R; Keshwani, P; Saxena, GN; Srivastava, S1
Bailey, T; Davies, M; Filetti, S; Furber, S; Garber, AJ; Montanya, E; Nauck, MA; Pratley, RE; Thomsen, AB1
Isogawa, A; Iwamoto, M; Koike, K; Ohki, T; Ohsugi, M; Omata, M; Tagawa, K; Toda, N; Yoshida, H1
Aono, M; Fujita, Y; Harashima, SI; Inagaki, N; Koizumi, T; Murata, Y; Ogura, M; Seike, M; Tanaka, D; Wang, Y; Yamane, S1
Crajoinas, RO; Fonseca-Alaniz, MH; Giannocco, G; Girardi, AC; Maciel, RM; Oliveira, KC; Salles, TA; Venturini, G1
Badole, SL; Bagul, PP; Bodhankar, SL; Coutinho, EC; Ghule, AE; Joshi, AC; Khedkar, VM; Khose, RD; Mahamuni, SP; Raut, CG; Wagh, NK1
Katz, DP; Sample, CH; Swithers, SE1
Cress, AB; Duleba, AJ; Ortega, I; Sokalska, A; Stanley, SD; Stener-Victorin, E; Villanueva, JA; Wong, DH1
Arjona Ferreira, JC; Barzilai, N; Goldstein, BJ; Golm, GT; Guo, H; Kaufman, KD; Marre, M; Sisk, CM1
Kanamori, A; Kubota, A; Maeda, H; Matsuba, I; Tanaka, Y; Terauchi, Y1
Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS1
Abecia, LC; Casado, A; Casis, L; Echevarría, E; Macarulla, MT; Portillo, MP; Rodríguez, VM; Saracíbar, G1
Cory-Slechta, DA; Reeves, R; Richfield, EK; Thiruchelvam, M2
Huhtaniemi, I; Li, X; Mäkelä, S; Poutanen, M; Santti, R; Strauss, L; Streng, T1
DuBois, DW; Frye, GD; Hsiao, SH; Miranda, RC1
Cory-Slechta, DA; Reeves, R; Thiruchelvam, M1
Adamson, P; Arguedas, AG; Arrieta, AC; Blumer, J; Driscoll, T; Karlsson, MO; Lutsar, I; Milligan, P; Saez-Llorens, X; Vora, AJ; Walsh, TJ; Wood, N1
Aglianò, M; Carminati, P; Lorenzoni, P; Pacifici, L; Ruggiero, V; Sorrentino, V; Stasi, MA; Taurelli, R; Ursillo, A; Weber, E1
Ben Ari, T; Ben Eliezer, M; Eshet, R; Gat-Yablonski, G; Maor, G; Phillip, M1
Cuzick, J; Locker, GY; Sainsbury, JR1
Balthazart, J; Cornil, CA; Holloway, KS; Taziaux, M1
Dix, DJ; Goetz, AK; Lambert, GR; Nesnow, S; Sun, G; Thai, SF; Tully, DB; Wolf, DC1
Arun, KH; Kaul, CL; Kumar, S; Sharma, SS1
Hazelton, GA; Juberg, DR; Mudra, DR; Parkinson, A1
Bhatnagar, AS; Evans, DB; Gasser, JA; Green, JR; Ingold, P; Rebmann, A; Shen, V1
Bergman, A; Blum, R; Chen, L; Dilzer, S; Herman, GA; Hilliard, D; Lasseter, K; Liu, F; Meehan, AG; Snyder, K; Stevens, C; Tanaka, W; Tanen, M; Wagner, JA; Wang, AQ; Zeng, W1
Best, DS; Blystone, CR; Dix, DJ; Goetz, AK; Murrell, RN; Narotsky, MG; Nichols, HP; Ren, H; Rockett, JC; Schmid, JE; Thillainadarajah, I; Thompson, KE; Wolf, DC1
Best, DS; Blystone, CR; Dix, DJ; Goetz, AK; Narotsky, MG; Nichols, HP; Ren, H; Rockett, JC; Schmid, JE; Strader, LF; Thillainadarajah, I; Wolf, DC1
Allen, JW; Delker, DA; George, MH; Hester, SD; Jones, C; Leavitt, S; Moore, T; Nelson, G; Nesnow, S; Roop, BC; Sun, G; Thai, SF; Ward, WO; Winkfield, E; Wolf, DC1
Farag, AT; Ibrahim, HH1
Kantesaria, B; Krishna, G; Martinho, M; Pedicone, L; Sansone-Parsons, A1
Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C1
Corradi, LS; Falleiros-Júnior, LR; Santos, FC; Taboga, SR; Vilamaior, PS1
Cajander, S; Holmäng, A; Lönn, M; Lystig, T; Mannerås, L; Seleskovic, Z; Stener-Victorin, E1
Reznikov, OH; Tarasenko, LV1
de Castro, VL; Destefani, CR; Diniz, C; Poli, P1
Foster, G; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A1
Baumane, L; Dambrova, M; Kalvinsh, I; Liepinsh, E; Muceniece, R; Vilskersts, R; Wikberg, JE; Zvejniece, L1
Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ1
Desfrere, L; Gressens, P; Olivier, P; Schwendimann, L; Verney, C1
Ahrén, B2
Ema, M; Hirata-Koizumi, M; Hirose, A; Imai, T; Kamata, E; Ogata, H1
Fetisovova, Z; Kajo, K; Kubatka, P; Nosalova, G; Sadlonova, V1
Alba, M; Amatruda, JM; Chen, Y; Hussain, S; Kaufman, KD; Langdon, RB; Raz, I; Stein, PP; Wu, M1
Davies, MJ; Engel, SS; Loeys, T; Scott, R1
Crownover, P; Damle, B; Glue, P; LaBadie, R1
Ema, M; Hirata-Koizumi, M; Hirose, A; Imai, T; Kamata, E; Matsuyama, T1
Fregly, MJ; Scammell, JG1
Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU1
Machera, K1
Brecht, HM; Haberstroh, U; Mihatsch, MJ; Oberle, G; Stahl, RA; Thaiss, F1
Feldman, D; Garland, WA; Kaufman, LS; Meschter, CL; Mico, BA; Mortillo, M; Riley, JA1
Chmielewski, PA; Dudchenko, P; Holley, LA; Miller, JA; Sarter, M1
Day, P; ElSourady, H; Hall, IH; Izydore, RA; Simlot, R; Wong, OT1
Bouillon, R; De Coster, R; Ederveen, AG; Nijs, J; van Herck, E; Vanderschueren, D1
Adén, U; Bona, E; Fredholm, BB; Gilland, E; Hagberg, H1
Ashby, J; Lefevre, PA1
Flanagan, AM; Lea, CK1
Buyse, J; De Coster, R; Decuypere, E; Dewil, E; Mast, J; Veldhuis, JD1
Huang, ML; Langenaecken, C; Piotrovsky, VK; Van Peer, A1
Bowden, C; DeCoster, R; Eto, I; Grubbs, CJ; Juliana, MM; Kelloff, GJ; Lubet, RA; Steele, VE; You, M1
Balthazart, J; Castagna, C; Panzica, GC; Russo, C; Tlemçani, O; Viglietti-Panzica, C1
Branch, RA; Carcillo, JA; Gillespie, DG; Jones, GS; Kochanek, PM; Korzekwa, KR; Kost, CK; Parise, RA; Whalen, MJ1
Vergieva, T1
Boonen, S; Bouillon, R; de Coster, R; Ederveen, AG; Moermans, K; Van Herck, E; Vandenput, L; Vanderschueren, D; Verstuyf, A1
Bikoff, J; Ginsberg, DL; Sussman, N1
Dunkel, L; Saukkonen, T; Wickman, S1
Bailey, L; Dunner, DL; Laird, LK; Seabolt, JL; Sussman, N; Zajecka, J1
Gotoh, M; Griffin, C; Hruban, Z1
Baron, RL; Baumel, I; Freudenthal, RI; Kerchner, GA; Persing, RL1
Akutsu, S; Iibo, K; Ishikawa, H; Matsuzaki, M; Nakamura, K1
Matsuzaki, M; Okuyama, D; Sekino, M; Tsuchida, M; Yoshida, A1
Hirata, A; Matsuzaki, M; Nakamura, K; Sakai, T; Sekino, M1
Calandra, JC; Keplinger, ML; Lyman, FL2
Graziani, M; Nencini, P; Valeri, P1
Byloos, M; De Coster, R; Goeminne, N; Van Ginckel, R; Vanherck, W; Wouters, W1
Prasad, RS; Vijayan, E1
Crook, D; Devenport, MH; Lees, LJ; Wynn, V1
Hrabálek, A; Nedvídková, J; Stolba, P; Vanzura, J; Vinsová, J1
Matsushima, R; Sumi, C; Yokoro, K1
Fregly, MJ1
Rechcigl, M2
Tjälve, H1
Matsushima, T; Weisburger, JH1
Gaines, TB; Kimbrough, RD; Linder, RE1
Carter, EA; Isselbacher, KJ1
Kroes, R; Verschuuren, HG1
Doniach, I; Swettenham, KV1
Laqueur, GL; Rechcigl, M1
Anton, AH; Fregly, MJ1

Reviews

16 review(s) available for triazoles and Body Weight

ArticleYear
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
    Hospital practice (1995), 2013, Volume: 41, Issue:2

    Topics: Adamantane; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Linagliptin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin

2013
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.
    Postgraduate medicine, 2013, Volume: 125, Issue:3

    Topics: Adamantane; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular System; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Lipids; Nitriles; Pyrazines; Pyrrolidines; Risk Factors; Sitagliptin Phosphate; Triazoles; Vildagliptin

2013
Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis.
    Current medical research and opinion, 2013, Volume: 29, Issue:11

    Topics: Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Metformin; Pyrazines; Sitagliptin Phosphate; Triazoles

2013
[Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison between canagliflozin and sitagliptin].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139 Suppl 2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiophenes; Triazoles; Young Adult

2014
Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Fasting; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Lipids; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2014
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction.
    Reproductive biomedicine online, 2016, Volume: 32, Issue:6

    Topics: Adult; Anovulation; Body Weight; Clomiphene; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; Letrozole; Life Style; Metformin; Nitriles; Overweight; Ovulation; Ovulation Induction; Patient Safety; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Retrospective Studies; Triazoles

2016
Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes.
    Arquivos brasileiros de endocrinologia e metabologia, 2008, Volume: 52, Issue:6

    Topics: Adamantane; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Nitriles; Peptides; Postprandial Period; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin

2008
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential.
    Vascular health and risk management, 2008, Volume: 4, Issue:6

    Topics: Adamantane; Blood Glucose; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Edema; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Nitriles; Pioglitazone; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Vildagliptin

2008
[New blood glucose-lowering drugs in type 2 diabetes: a review of the literature].
    Nederlands tijdschrift voor geneeskunde, 2010, Volume: 154

    Topics: Adamantane; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liraglutide; Nitriles; Peptides; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms; Vildagliptin

2010
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Health technology assessment (Winchester, England), 2010, Volume: 14, Issue:36

    Topics: Adamantane; Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Nitriles; Peptides; Pyrazines; Pyrrolidines; Quality of Life; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; State Medicine; Thiazolidinediones; Triazoles; United Kingdom; Venoms; Vildagliptin

2010
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:8

    Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Liraglutide; Male; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms

2012
DPP-4 inhibitors.
    Best practice & research. Clinical endocrinology & metabolism, 2007, Volume: 21, Issue:4

    Topics: Adamantane; Animals; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Metabolism; Metformin; Nitriles; Pioglitazone; Protease Inhibitors; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Substrate Specificity; Thiazolidinediones; Triazoles; Vildagliptin

2007
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
    Current diabetes reports, 2007, Volume: 7, Issue:5

    Topics: Adamantane; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Exenatide; Gastric Emptying; Glucagon-Like Peptide 1; Hypoglycemic Agents; Incretins; Islets of Langerhans; Liraglutide; Nitriles; Peptides; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin

2007
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
    Expert opinion on investigational drugs, 2008, Volume: 17, Issue:6

    Topics: Adamantane; Body Weight; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Secretion; Nausea; Nitriles; Peptides; Pyrazines; Pyrrolidines; Randomized Controlled Trials as Topic; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin; Vomiting

2008
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain

2001
Six-year perspectives on the safety and tolerability of nefazodone.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Obesity; Piperazines; Priapism; Seizures; Sexual Dysfunctions, Psychological; Suicide; Triazoles

2002

Trials

34 trial(s) available for triazoles and Body Weight

ArticleYear
[Comparative clinical study of pharmacokinetics and bioequivalence of Relonova and Maxalt].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Volume: 123, Issue:8

    Topics: Adult; Body Weight; Female; Humans; Male; Therapeutic Equivalency; Triazoles; Tryptamines; Young Adult

2023
Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles

2013
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:8

    Topics: Administration, Oral; Argentina; Blood Glucose; Body Weight; Canada; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; India; Insulin, Long-Acting; Male; Mexico; Middle Aged; Pyrazines; Sitagliptin Phosphate; South Africa; Treatment Outcome; Triazoles; Turkey; United States

2013
Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data.
    Postgraduate medicine, 2013, Volume: 125, Issue:3

    Topics: Blood Glucose; Body Weight; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Peptides; Pyrazines; Retrospective Studies; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms

2013
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.
    Diabetologia, 2013, Volume: 56, Issue:12

    Topics: Adolescent; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles

2013
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.
    Current medical research and opinion, 2014, Volume: 30, Issue:2

    Topics: Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Exercise; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Placebos; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Triazoles; Triglycerides; Weight Loss

2014
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
    Diabetes care, 2014, Volume: 37, Issue:3

    Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Urinary Tract Infections; Weight Loss

2014
The effects of dipeptidyl peptidase-4 inhibitors in treatment of obese patients with type 2 diabetes.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2013, Volume: 67, Issue:5

    Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Obesity; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Triglycerides

2013
A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus--a randomized controlled trial START-J study.
    Cardiovascular diabetology, 2014, May-24, Volume: 13

    Topics: Adiponectin; Aged; Asian People; Biomarkers; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles

2014
HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.
    Diabetes care, 2014, Volume: 37, Issue:8

    Topics: Aged; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Triazoles

2014
The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes.
    Postgraduate medicine, 2014, Volume: 126, Issue:3

    Topics: Adult; Age Factors; Aged; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Health Behavior; Humans; Hypoglycemic Agents; Male; Middle Aged; Personal Satisfaction; Pyrazines; Quality of Life; Self Efficacy; Sex Factors; Sexual Behavior; Sitagliptin Phosphate; Thiophenes; Triazoles; Weight Loss

2014
Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.
    Diabetes technology & therapeutics, 2014, Volume: 16, Issue:10

    Topics: Adult; Asian People; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles

2014
Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.
    The American journal of managed care, 2014, Volume: 20, Issue:13 Suppl

    Topics: Blood Pressure; Body Mass Index; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles

2014
Impact of Male and Female Weight, Smoking, and Intercourse Frequency on Live Birth in Women With Polycystic Ovary Syndrome.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Clomiphene; Coitus; Female; Fertility Agents, Female; Humans; Infant, Newborn; Infertility, Male; Letrozole; Live Birth; Male; Nitriles; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Smoking; Triazoles; Young Adult

2015
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Metabolism: clinical and experimental, 2010, Volume: 59, Issue:6

    Topics: Adiponectin; Blood Glucose; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Drug Therapy, Combination; Exercise; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Resistin; Sitagliptin Phosphate; Thiazolidinediones; Triazoles; Tumor Necrosis Factor-alpha

2010
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.
    Diabetes care, 2011, Volume: 34, Issue:2

    Topics: Adult; Body Weight; Diabetes Mellitus, Type 2; Exenatide; Female; Health Status; Humans; Hypoglycemic Agents; Male; Mental Health; Middle Aged; Patient Satisfaction; Peptides; Pioglitazone; Pyrazines; Quality of Life; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Venoms

2011
Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:10

    Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Aryl Hydrocarbon Hydroxylases; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP2A6; Estradiol; Estrone; Female; Genotype; Humans; Letrozole; Nitriles; Polymorphism, Genetic; Postmenopause; Triazoles

2011
Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.
    Diabetes research and clinical practice, 2011, Volume: 94, Issue:2

    Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Down-Regulation; Female; Ghrelin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Turkey

2011
Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:9

    Topics: Adult; Aged; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Waist Circumference

2012
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
    Lancet (London, England), 2012, Jun-16, Volume: 379, Issue:9833

    Topics: Adult; Aged; Body Weight; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2012
Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
    The Journal of the Association of Physicians of India, 2012, Volume: 60

    Topics: Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triazoles

2012
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial.
    Diabetes care, 2012, Volume: 35, Issue:10

    Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Liraglutide; Metformin; Nausea; Patient Satisfaction; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2012
Efficacy and safety of switching from basal insulin to sitagliptin in Japanese type 2 diabetes patients.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2013, Volume: 45, Issue:3

    Topics: Aged; Asian People; Body Mass Index; Body Weight; C-Peptide; Demography; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Pyrazines; ROC Curve; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2013
Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency.
    Diabetes care, 2013, Volume: 36, Issue:5

    Topics: Body Weight; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Pyrazines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles

2013
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Aging; Alleles; Antifungal Agents; Body Weight; Child; Child, Preschool; Cohort Studies; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2004
Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
    Cancer, 2004, Aug-15, Volume: 101, Issue:4

    Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Chemotherapy, Adjuvant; Decision Making; Female; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Odds Ratio; Postmenopause; Risk Factors; Tamoxifen; Triazoles; United Kingdom; United States

2004
Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:8

    Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Administration, Oral; Blood Glucose; Body Weight; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycoproteins; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Pyrazines; Sitagliptin Phosphate; Triazoles

2006
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Body Surface Area; Body Weight; Child; Female; Humans; Male; Mycoses; Treatment Outcome; Triazoles

2007
Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Age Factors; Alkynes; Antifungal Agents; Area Under Curve; Benzoxazines; Body Weight; Capsules; Creatine Kinase; Cyclopropanes; Drug Interactions; Heart Block; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Tablets; Triazoles; Voriconazole

2008
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles

2007
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes.
    Current medical research and opinion, 2008, Volume: 24, Issue:2

    Topics: Adult; Aged; Area Under Curve; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2008
Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes.
    Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:10

    Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Metformin; Middle Aged; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Triglycerides

2008
The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
    European journal of endocrinology, 2002, Volume: 146, Issue:3

    Topics: Adolescent; Aromatase Inhibitors; Body Composition; Body Height; Body Weight; Double-Blind Method; Enzyme Inhibitors; Estradiol; Gonadal Steroid Hormones; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Letrozole; Lipids; Male; Nitriles; Prospective Studies; Puberty; Puberty, Delayed; Testosterone; Triazoles

2002
Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:6

    Topics: Adult; Antifungal Agents; Apolipoproteins; Body Weight; Contraceptives, Oral, Hormonal; Female; Fluconazole; Glucose Tolerance Test; Gonadal Steroid Hormones; Hormones; Humans; Hydrocortisone; Lipids; Lipoproteins; Sex Hormone-Binding Globulin; Triazoles

1989

Other Studies

163 other study(ies) available for triazoles and Body Weight

ArticleYear
Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.
    Nutrients, 2021, Nov-15, Volume: 13, Issue:11

    Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Weight; Dietary Supplements; Disease Models, Animal; Epilepsy, Absence; Injections, Intraperitoneal; Ketones; Ketosis; Lipopolysaccharides; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptors, Purinergic P1; Triazoles; Xanthines

2021
1,2,3-Triazolyl ester of ketorolac (15K), a potent PAK1 blocker, inhibits both growth and metastasis of orthotopic human pancreatic cancer xenografts in mice.
    Drug discoveries & therapeutics, 2019, Nov-14, Volume: 13, Issue:5

    Topics: Animals; Body Weight; Cell Line, Tumor; Cell Proliferation; Esters; Hemodynamics; Humans; Inhibitory Concentration 50; Ketorolac; Mice; Mice, Nude; Neoplasm Invasiveness; Triazoles; Xenograft Model Antitumor Assays

2019
Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice.
    International journal of obesity (2005), 2020, Volume: 44, Issue:8

    Topics: Abdominal Fat; Adipose Tissue, White; Animals; Body Weight; Diabetes Mellitus, Type 2; Dyslipidemias; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Obesity; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Poly ADP Ribosylation; Sulfones; Tankyrases; Triazoles

2020
3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Body Weight; Disease Models, Animal; Male; Metabolic Syndrome; Mice; Triazoles

2020
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole.
    Pediatric transplantation, 2020, Volume: 24, Issue:6

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Weight; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Invasive Fungal Infections; Male; Neoplasms; Retrospective Studies; Tablets; Treatment Outcome; Triazoles; Young Adult

2020
Short-term toxicity study of 1-aminobenzotraizole, a CYP inhibitor, in Wistar rats.
    Drug and chemical toxicology, 2022, Volume: 45, Issue:4

    Topics: Animals; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Male; Organ Size; Rats; Rats, Wistar; Toxicity Tests; Triazoles

2022
Exercise differentially affects metabolic functions and white adipose tissue in female letrozole- and dihydrotestosterone-induced mouse models of polycystic ovary syndrome.
    Molecular and cellular endocrinology, 2017, 06-15, Volume: 448

    Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Animals; Body Composition; Body Weight; Cell Size; Dihydrotestosterone; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Glucose Tolerance Test; Insulin Resistance; Letrozole; Lipid Metabolism; Liver; Mice, Inbred C57BL; Nitriles; Organ Size; Phenotype; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Signal Transduction; Triazoles; Triglycerides

2017
Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
    Journal of ovarian research, 2017, Sep-15, Volume: 10, Issue:1

    Topics: Androgen Antagonists; Animals; Blood Glucose; Body Weight; Catalase; Estradiol; Female; gamma-Aminobutyric Acid; Insulin Resistance; Letrozole; Nitriles; Ovary; Peroxidase; Polycystic Ovary Syndrome; Protective Agents; Rats; Reproduction; Superoxide Dismutase; Testosterone; Triazoles

2017
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.
    Scientific reports, 2017, 10-12, Volume: 7, Issue:1

    Topics: Animals; Autophagy; Biomarkers; Body Weight; Cachexia; Cisplatin; Disease Models, Animal; Forkhead Box Protein O3; Growth Hormone; Indoles; Male; Mitochondria; Mitochondrial Dynamics; Muscle, Skeletal; Oligopeptides; Organ Size; Organelle Biogenesis; Oxidative Stress; Phosphorylation; Piperidines; Proto-Oncogene Proteins c-akt; Rats; Secretagogues; Triazoles

2017
Oxidative stress burden inhibits spermatogenesis in adult male rats: testosterone protective effect.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:4

    Topics: Aging; Animals; Biomarkers; Body Weight; Estradiol; Follicle Stimulating Hormone; Grape Seed Extract; Inflammation; Letrozole; Male; Methotrexate; Nitriles; Organ Size; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Seminiferous Tubules; Sperm Count; Sperm Motility; Spermatogenesis; Testosterone; Triazoles

2018
Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Endocrinology, 2018, 04-01, Volume: 159, Issue:4

    Topics: Adipocytes; Androgen Antagonists; Animals; Aromatase Inhibitors; Body Weight; Disease Models, Animal; Estrous Cycle; Female; Flutamide; Follicle Stimulating Hormone; Letrozole; Luteinizing Hormone; Mice; Nitriles; Ovary; Phenotype; Pituitary Gland; Polycystic Ovary Syndrome; Receptors, LHRH; Reproduction; Steroid 17-alpha-Hydroxylase; Testosterone; Triazoles

2018
Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB.
    Chemico-biological interactions, 2018, Apr-25, Volume: 286

    Topics: Aging; Animals; Anticonvulsants; Body Weight; Brain-Derived Neurotrophic Factor; Cognition; CREB-Binding Protein; Dentate Gyrus; Gene Expression Regulation; Gerbillinae; Insulin-Like Growth Factor I; Ki-67 Antigen; Male; Microscopy, Fluorescence; Neurogenesis; Receptor, IGF Type 1; Receptor, trkB; Triazoles

2018
Penconazole alters redox status, cholinergic function and lung's histoarchitecture of adult rats: Reversal effect of vitamin E.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102

    Topics: Acetylcholinesterase; Animals; Antioxidants; Body Weight; Cholinergic Agents; Hydrogen Peroxide; Lipid Peroxidation; Lung; Lung Injury; Male; Malondialdehyde; Organ Size; Oxidation-Reduction; Rats, Wistar; Triazoles; Vitamin E

2018
Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Journal of ovarian research, 2018, Apr-03, Volume: 11, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Biopsy; Body Weight; Disease Management; Disease Models, Animal; Estrous Cycle; Female; Humans; Letrozole; Lipid Metabolism; Lipids; Nitriles; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Quercetin; Rats; Triazoles

2018
Long chain fatty acid coenzyme A ligase (FACL) regulates triazophos-induced stimulation of reproduction in the small brown planthopper (SBPH), Laodelphax striatellus (Fallen).
    Pesticide biochemistry and physiology, 2018, Volume: 148

    Topics: Animals; Body Weight; Coenzyme A Ligases; Down-Regulation; Female; Gene Expression; Gene Silencing; Glycerol; Hemiptera; Insecticides; Organothiophosphates; Oryza; Plant Diseases; Proteomics; Real-Time Polymerase Chain Reaction; Reproduction; Triazoles; Up-Regulation; Zea mays

2018
Ghrelin Receptor Antagonism of Methamphetamine-Induced Conditioned Place Preference and Intravenous Self-Administration in Rats.
    International journal of molecular sciences, 2018, Sep-26, Volume: 19, Issue:10

    Topics: Administration, Intravenous; Analysis of Variance; Animals; Body Weight; Central Nervous System Stimulants; Conditioning, Psychological; Glycine; Male; Methamphetamine; Rats, Wistar; Receptors, Ghrelin; Self Administration; Spatial Behavior; Time Factors; Triazoles

2018
Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
    Laboratory investigation; a journal of technical methods and pathology, 2019, Volume: 99, Issue:8

    Topics: Adipose Tissue, White; Animals; Body Weight; Diet, High-Fat; Fatty Liver; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; N-substituted Glycines; Obesity; Prolyl Hydroxylases; Pyridines; Triazoles

2019
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Acta pharmacologica Sinica, 2019, Volume: 40, Issue:12

    Topics: Adolescent; Antifungal Agents; Asian People; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Models, Biological; Polymorphism, Genetic; Transplantation, Homologous; Triazoles

2019
Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
    Chemico-biological interactions, 2013, Apr-25, Volume: 203, Issue:2

    Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Molecular Docking Simulation; Niacinamide; Oxidative Stress; Pancreas; Peptide Fragments; Protein Conformation; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles

2013
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
    British journal of pharmacology, 2013, Volume: 169, Issue:5

    Topics: Adamantane; Animals; Blood Glucose; Blood Pressure; Body Weight; Cardiotonic Agents; Cholesterol; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Heart; Heart Rate; Insulin; Insulin Resistance; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria, Heart; Nitriles; Obesity; Oxidative Stress; Pyrazines; Pyrrolidines; Rats, Wistar; Reactive Oxygen Species; Sitagliptin Phosphate; Triazoles; Vildagliptin

2013
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.
    International journal of cancer, 2013, Nov-15, Volume: 133, Issue:10

    Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Carcinogenesis; Colonic Neoplasms; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Intestinal Mucosa; Intestines; Male; Mucins; Pyrazines; Random Allocation; Rats; Rats, Inbred F344; Reactive Oxygen Species; Sitagliptin Phosphate; Triazoles

2013
Chelation of chromium(VI) by combining deferasirox and deferiprone in rats.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2013, Volume: 26, Issue:3

    Topics: Animals; Benzoates; Body Weight; Chelating Agents; Chelation Therapy; Chromium; Deferasirox; Deferiprone; Male; Molecular Structure; Pyridones; Rats; Rats, Wistar; Tissue Distribution; Triazoles

2013
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.
    Diabetes/metabolism research and reviews, 2014, Volume: 30, Issue:3

    Topics: Animals; Blood Glucose; Body Weight; Bone and Bones; Cell Differentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Histocytochemistry; Male; Mice; Osteoblasts; Polymerase Chain Reaction; RNA; Triazoles; X-Ray Microtomography

2014
Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking Behavior; Feeding Behavior; Glucagon-Like Peptide 1; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Niacinamide; Oxidative Stress; Pancreas; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Staining and Labeling; Streptozocin; Triazoles; Triterpenes

2013
Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model.
    European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3

    Topics: Animals; Apoptosis; Body Weight; Cardiotonic Agents; Creatine Kinase, MB Form; Disease Models, Animal; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutathione Peroxidase; Heart; Heart Ventricles; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocytes, Cardiac; Organ Size; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Reperfusion Injury; Sitagliptin Phosphate; Superoxide Dismutase; Triazoles

2013
Combined repeated-dose and reproductive/developmental toxicity screening test of 3-amino-5-mercapto-1,2,4-triazole in rats.
    The Journal of toxicological sciences, 2013, Volume: 38, Issue:5

    Topics: Anemia; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Female; Hepatocytes; Hypertrophy; Kidney Tubules; Litter Size; Male; No-Observed-Adverse-Effect Level; Organ Size; Pituitary Gland; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Structure-Activity Relationship; Thyroid Gland; Toxicity Tests; Triazoles

2013
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
    Endocrinology, 2013, Volume: 154, Issue:12

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Blood Glucose; Body Weight; Brain; Dietary Fats; Dose-Response Relationship, Drug; Energy Metabolism; Female; Gene Expression Regulation, Enzymologic; Genotype; Glucose; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Knockout; Molecular Structure; Pyrazoles; Pyrimidines; RNA, Messenger; Triazoles

2013
Assessment of a nonsteroidal aromatase inhibitor, letrozole, in juvenile rats.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2013, Volume: 98, Issue:5

    Topics: Animals; Aromatase Inhibitors; Behavior, Animal; Body Weight; Bone Development; Dose-Response Relationship, Drug; Eating; Female; Letrozole; Male; Motor Activity; Nitriles; Rats; Rats, Sprague-Dawley; Reproduction; Spermatozoa; Triazoles

2013
Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Heart; Heart Function Tests; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Pyrazines; Sitagliptin Phosphate; Triazoles

2014
Characterization of the exocrine pancreas in the male Zucker diabetic fatty rat model of type 2 diabetes mellitus following 3 months of treatment with sitagliptin.
    Endocrinology, 2014, Volume: 155, Issue:3

    Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Keratins; Ki-67 Antigen; Male; Metformin; Pancreas, Exocrine; Pyrazines; Rats; Rats, Zucker; Sitagliptin Phosphate; Triazoles

2014
Chronic effects of strobilurin fungicides on development, growth, and mortality of larval Great Plains toads (Bufo cognatus).
    Ecotoxicology (London, England), 2014, Volume: 23, Issue:3

    Topics: Acetates; Animals; Body Weight; Bufonidae; Carbamates; Dose-Response Relationship, Drug; Drug Combinations; Female; Fungicides, Industrial; Larva; Male; Metamorphosis, Biological; Methacrylates; Mortality; Pyrazoles; Pyrimidines; Strobilurins; Toxicity Tests, Chronic; Triazoles; Water Pollutants, Chemical

2014
Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.
    Endocrinology, 2014, Volume: 155, Issue:6

    Topics: Animals; Body Weight; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Insulin Resistance; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Obesity; Triazoles

2014
Stereoselectivity in bioaccumulation and excretion of epoxiconazole by mealworm beetle (Tenebrio molitor) larvae.
    Ecotoxicology and environmental safety, 2014, Volume: 107

    Topics: Animals; Body Weight; Diet; Epoxy Compounds; Fungicides, Industrial; Larva; Stereoisomerism; Tandem Mass Spectrometry; Tenebrio; Triazoles

2014
Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.
    Molecular and cellular endocrinology, 2014, Aug-05, Volume: 393, Issue:1-2

    Topics: Adipose Tissue; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Mice; Mice, Inbred C57BL; Picolinic Acids; Receptors, Ghrelin; Triazoles

2014
DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats.
    American journal of physiology. Endocrinology and metabolism, 2014, Sep-01, Volume: 307, Issue:5

    Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Compressive Strength; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Male; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Streptozocin; Stress, Mechanical; Triazoles

2014
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014, Volume: 24, Issue:12

    Topics: Adamantane; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Italy; Male; Metformin; Middle Aged; Monitoring, Physiologic; Nitriles; Peptides; Pyrazines; Pyrrolidines; Registries; Sex Factors; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin

2014
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:8

    Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Blood Cells; Body Weight; Brain Injuries; Disease Models, Animal; Ischemic Attack, Transient; Male; Myelin-Associated Glycoprotein; Neurologic Examination; Pyrimidines; Rats; Rats, Wistar; Time Factors; Triazoles

2015
JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
    European journal of pharmacology, 2015, Jul-05, Volume: 758

    Topics: Acyltransferases; Animals; Body Weight; Chlorocebus aethiops; COS Cells; Diet, High-Fat; Eating; Glucose Tolerance Test; Humans; Intestinal Absorption; Lipid Metabolism; Male; Mice; Obesity; Oxygen Consumption; Peptide YY; Piperazines; Rats; Triazoles

2015
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis.
    Mycoses, 2015, Volume: 58, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Biological Availability; Body Mass Index; Body Weight; Delayed-Action Preparations; Diarrhea; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Triazoles; Young Adult

2015
Central leptin resistance and hypothalamic inflammation are involved in letrozole-induced polycystic ovary syndrome rats.
    Biochemical and biophysical research communications, 2016, 08-05, Volume: 476, Issue:4

    Topics: Animals; Body Weight; Eating; Female; Hypothalamus; Inflammation; Leptin; Letrozole; Nitriles; Ovary; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Suppressor of Cytokine Signaling 3 Protein; Triazoles

2016
Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
    Reproductive sciences (Thousand Oaks, Calif.), 2017, Volume: 24, Issue:3

    Topics: Animals; Aromatase Inhibitors; Body Weight; Disease Models, Animal; Female; Follicle Stimulating Hormone; Insulin; Leptin; Letrozole; Nitriles; Obesity; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Progesterone; Rats; Testosterone; Triazoles

2017
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
    Endocrine, 2017, Volume: 58, Issue:1

    Topics: Animals; Animals, Newborn; Antineoplastic Agents; Body Weight; Cachexia; Calcium; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Eating; Growth Hormone; Indoles; Male; Muscle, Skeletal; Piperidines; Rats; Rats, Wistar; Receptors, Ghrelin; Triazoles; Wasting Disease, Chronic

2017
Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
    Current drug metabolism, 2016, Volume: 17, Issue:10

    Topics: Administration, Oral; Animals; Body Weight; Enoxacin; Fluoroquinolones; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Models, Biological; Monosaccharides; Sildenafil Citrate; Triazoles; Venlafaxine Hydrochloride

2016
Epoxiconazole causes changes in testicular histology and sperm production in the Japanese quail (Coturnix coturnix japonica).
    Environmental toxicology and chemistry, 2008, Volume: 27, Issue:11

    Topics: Animals; Body Weight; Coturnix; Dose-Response Relationship, Drug; Epoxy Compounds; Female; Fungicides, Industrial; Male; Organ Size; Spermatozoa; Testis; Triazoles

2008
Effects of maternal exposure to an aromatase inhibitor on sexual behaviour and neurochemical and endocrine aspects of adult male rat.
    Reproduction, fertility, and development, 2008, Volume: 20, Issue:5

    Topics: Animals; Aromatase Inhibitors; Biogenic Monoamines; Body Weight; Brain Chemistry; Endocrine System; Female; Letrozole; Male; Maternal Exposure; Nitriles; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sexual Behavior, Animal; Testosterone; Triazoles

2008
Uterotrophic assay, Hershberger assay, and subacute oral toxicity study of 3-amino-1,2,4-triazole based on the Organization for Economic Co-operation and Development draft protocols.
    Archives of toxicology, 2009, Volume: 83, Issue:5

    Topics: Administration, Oral; Animals; Antithyroid Agents; Biological Assay; Body Weight; Dose-Response Relationship, Drug; Endocrine Disruptors; Female; Guidelines as Topic; Injections, Subcutaneous; Male; Orchiectomy; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thyrotropin; Thyroxine; Time Factors; Toxicity Tests, Acute; Triazoles; Triiodothyronine; Uracil; Uterus

2009
Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in mice.
    Endocrinology, 2009, Volume: 150, Issue:1

    Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucose Clamp Technique; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms

2009
Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo.
    Toxicology and applied pharmacology, 2009, Jan-15, Volume: 234, Issue:2

    Topics: Animals; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Fungicides, Industrial; Gene Expression Profiling; Liver; Male; Mice; Microsomes, Liver; Nitriles; Organ Size; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Electrospray Ionization; Tretinoin; Triazoles

2009
Side effects of anastrozole in the experimental pre-menopausal mammary carcinogenesis.
    Neoplasma, 2009, Volume: 56, Issue:2

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitriles; Rats; Rats, Sprague-Dawley; Triazoles; Uterus; Vagina

2009
Collaborative work on evaluation of ovarian toxicity. 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats.
    The Journal of toxicological sciences, 2009, Volume: 34 Suppl 1

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Corpus Luteum; Drug Administration Schedule; Estrous Cycle; Female; Fertility; Japan; Male; Nitriles; Organ Size; Ovarian Follicle; Ovary; Pregnancy; Public-Private Sector Partnerships; Rats; Rats, Inbred F344; Societies, Scientific; Specific Pathogen-Free Organisms; Toxicity Tests; Triazoles; Uterus

2009
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Autonomic & autacoid pharmacology, 2009, Volume: 29, Issue:1-2

    Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation

2009
Gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats: relationship to the plasma concentration, in vitro hepatic metabolism, and effects on hepatic metabolizing enzyme activity.
    Drug and chemical toxicology, 2009, Volume: 32, Issue:3

    Topics: Administration, Oral; Animals; Body Weight; Chromatography, High Pressure Liquid; Female; In Vitro Techniques; Liver; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Rats; Rats, Sprague-Dawley; Ribosomal Protein S9; Ribosomal Proteins; Sex Factors; Tandem Mass Spectrometry; Toxicity Tests; Triazoles

2009
Effect of mitratapide on body composition, body measurements and glucose tolerance in obese Beagles.
    Veterinary research communications, 2009, Volume: 33, Issue:8

    Topics: Absorptiometry, Photon; Adipose Tissue; Animals; Anti-Obesity Agents; Body Composition; Body Weight; Dog Diseases; Dogs; Eating; Female; Glucose Tolerance Test; Obesity; Piperazines; Triazoles

2009
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
    Schizophrenia research, 2009, Volume: 115, Issue:1

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Body Composition; Body Weight; Clozapine; Dibenzothiazepines; Dietary Fats; Disease Models, Animal; Eating; Exenatide; Food Preferences; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Peptides; Pyrazines; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Venoms

2009
Short-term exposure to sublethal tebuconazole induces physiological impairment in male zebrafish (Danio rerio).
    Ecotoxicology and environmental safety, 2010, Volume: 73, Issue:3

    Topics: Animals; Biomarkers; Body Weight; Environmental Exposure; Enzymes; Fungicides, Industrial; Glucose; Lactates; Lethal Dose 50; Lipid Metabolism; Male; Recovery of Function; Time Factors; Toxicity Tests, Acute; Triazoles; Vitellogenins; Zebrafish

2010
Uterine and fetal blood flow indexes and fetal growth assessment after chronic estrogen suppression in the second half of baboon pregnancy.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:3

    Topics: Animals; Aromatase Inhibitors; Blood Pressure; Body Weight; Estradiol; Estrogens; Female; Fetal Development; Fetus; Letrozole; Models, Animal; Nitriles; Papio anubis; Placental Circulation; Pregnancy; Pregnancy, Animal; Regional Blood Flow; Triazoles; Umbilical Arteries; Uterus

2010
Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.
    Journal of diabetes science and technology, 2009, Volume: 3, Issue:1

    Topics: Body Weight; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Metformin; Models, Theoretical; Pyrazines; Sitagliptin Phosphate; Triazoles

2009
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:5

    Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Culture Media; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Eicosanoids; Glucagon-Like Peptide 1; Hypertrophy, Left Ventricular; Hypoglycemic Agents; In Vitro Techniques; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Phospholipases A2; Pioglitazone; Prostaglandin-Endoperoxide Synthases; Protective Agents; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles

2010
Deferasirox decreases age-associated iron accumulation in the aging F344XBN rat heart and liver.
    Cardiovascular toxicology, 2010, Volume: 10, Issue:2

    Topics: Aging; Animals; Apoptosis; Benzoates; Body Weight; Deferasirox; Heart; In Situ Nick-End Labeling; Iron; Iron Chelating Agents; Iron Overload; Liver; Male; Myocardium; Myocytes, Cardiac; Organ Size; Rats; Rats, Inbred F344; Trace Elements; Triazoles

2010
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
    Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:12

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Body Weight; Child Development; Child, Preschool; Drug Therapy, Combination; Humans; Male; Nitriles; Point Mutation; Puberty, Precocious; Receptors, LH; Tosyl Compounds; Triazoles

2009
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

    Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents

2010
Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database.
    Advances in therapy, 2010, Volume: 27, Issue:4

    Topics: Adult; Age Factors; Aged; Body Mass Index; Body Weight; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insurance Claim Review; Lipids; Male; Middle Aged; Peptides; Pyrazines; Retrospective Studies; Sex Factors; Sitagliptin Phosphate; Socioeconomic Factors; Triazoles; Venoms

2010
CYP26A1-specific antagonist influence on embryonic implantation, gene expression and endogenous retinoid concentration in rats.
    Reproductive toxicology (Elmsford, N.Y.), 2010, Volume: 30, Issue:3

    Topics: Animals; Benzothiazoles; Body Weight; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Embryo Implantation; Female; Gene Expression; Liver; Organ Size; Pregnancy; Rats; Rats, Wistar; Retinoic Acid 4-Hydroxylase; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Uterus

2010
Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat).
    Mediators of inflammation, 2010, Volume: 2010

    Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glycated Hemoglobin; Insulin; Insulin Resistance; Interleukin-1beta; Lipids; Male; Oxidative Stress; Pancreas; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles

2010
Removal of thallium by deferasirox in rats as biological model.
    Journal of applied toxicology : JAT, 2011, Volume: 31, Issue:2

    Topics: Animals; Benzoates; Body Weight; Chelating Agents; Chelation Therapy; Deferasirox; Disease Models, Animal; Dose-Response Relationship, Drug; Heavy Metal Poisoning; Iron; Male; Metals, Heavy; Poisoning; Random Allocation; Rats; Rats, Wistar; Spectrophotometry, Atomic; Thallium; Triazoles

2011
Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
    Clinical science (London, England : 1979), 2011, Volume: 120, Issue:2

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Diet; Dipeptidyl-Peptidase IV Inhibitors; Drinking; Drug Evaluation, Preclinical; Eating; Exenatide; Fatty Liver; Fructose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Metabolic Syndrome; Peptides; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Venoms

2011
[New data from the US-American Diabetes Congress. GLP-1 effect: more than reducing blood glucose].
    MMW Fortschritte der Medizin, 2010, Oct-07, Volume: 152, Issue:40

    Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Liraglutide; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Triazoles

2010
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:2

    Topics: Adipocytes; Adipose Tissue; Adiposity; Animals; Anti-Inflammatory Agents; Body Weight; Cytokines; Dipeptidyl-Peptidase IV Inhibitors; Flow Cytometry; Glucose; Glucose Intolerance; Glucose Tolerance Test; Immunohistochemistry; Inflammation; Insulin; Islets of Langerhans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophil Infiltration; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; Sitagliptin Phosphate; Triazoles

2011
A novel approach for long-term oral drug administration in animal research.
    Journal of neuroscience methods, 2011, Feb-15, Volume: 195, Issue:2

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Anastrozole; Animal Experimentation; Animals; Antipsychotic Agents; Body Weight; Chromatography, Liquid; Disease Models, Animal; Female; Gels; Humans; Mass Spectrometry; Mice; Mice, Transgenic; Nitriles; Presenilin-1; Reproducibility of Results; tau Proteins; Triazoles

2011
Effectiveness of sitagliptin in asian Indian patients with type 2 diabetes-an Indian tertiary diabetes care center experience.
    Diabetes technology & therapeutics, 2011, Volume: 13, Issue:1

    Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; India; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Middle Aged; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Statistics, Nonparametric; Triazoles; Triglycerides

2011
Propiconazole induces alterations in the hepatic metabolome of mice: relevance to propiconazole-induced hepatocarcinogenesis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 120, Issue:2

    Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Fungicides, Industrial; Liver; Male; Metabolome; Mice; Mice, Inbred Strains; Molecular Structure; Organ Size; Triazoles

2011
Growth arrest-specific protein 6 receptor antagonism impairs adipocyte differentiation and adipose tissue development in mice.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2

    Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Benzocycloheptenes; Blood Glucose; Body Temperature; Body Weight; Cell Differentiation; Cell Size; Cells, Cultured; Embryonic Stem Cells; Intercellular Signaling Peptides and Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Organ Size; Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Triazoles

2011
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:3

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles

2011
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Spasms, Infantile; Triazoles; Valproic Acid; Young Adult

2011
Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1

    Topics: Adiposity; Animals; Anti-Obesity Agents; Body Weight; Brain; Calibration; Conditioning, Operant; Data Interpretation, Statistical; Drinking Behavior; Feeding Behavior; Food Preferences; Guanosine 5'-O-(3-Thiotriphosphate); Indans; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Satiety Response; Triazoles; Weight Loss

2011
Effects of DPP-4 inhibition on cardiac metabolism and function in mice.
    Journal of molecular and cellular cardiology, 2011, Volume: 51, Issue:6

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Body Weight; CD36 Antigens; Cell Membrane; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Glucose Tolerance Test; Glucose Transporter Type 4; Glycation End Products, Advanced; Guanine; Heart; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Phosphorylation; Protein Transport; Pyrazines; Sitagliptin Phosphate; Triazoles; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2011
[The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters].
    Actas urologicas espanolas, 2012, Volume: 36, Issue:3

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Biomarkers; Body Weight; Catalase; Diet, High-Fat; Glutathione; Gonadal Steroid Hormones; Infertility, Male; Lipid Peroxidation; Lipids; Male; Nitric Oxide; Nitriles; Obesity; Oxidative Stress; Pituitary Hormones, Anterior; Random Allocation; Rats; Rats, Wistar; Spermatogenesis; Superoxide Dismutase; Superoxide Dismutase-1; Testis; Triazoles

2012
Both sitagliptin analogue & pioglitazone preserve the beta-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice.
    BMB reports, 2011, Volume: 44, Issue:11

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Fasting; Glucose Tolerance Test; Homeostasis; Insulin-Secreting Cells; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Organ Size; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles

2011
Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats.
    Toxicology and industrial health, 2012, Volume: 28, Issue:1

    Topics: Animals; Benzoates; Body Weight; Cadmium; Chelating Agents; Chelation Therapy; Deferasirox; Deferoxamine; Iron; Male; Rats; Rats, Wistar; Tissue Distribution; Triazoles

2012
Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).
    Experimental diabetes research, 2011, Volume: 2011

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Insulin; Kidney Glomerulus; Lipid Peroxidation; Lipids; Male; Obesity; Pyrazines; Rats; Rats, Zucker; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2011
The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
    American journal of physiology. Gastrointestinal and liver physiology, 2012, Apr-15, Volume: 302, Issue:8

    Topics: Allylamine; Animals; Anticholesteremic Agents; Apoptosis; Bile Acids and Salts; Blood Glucose; Body Weight; Cell Proliferation; Cell Size; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Diet; Drug Synergism; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin; Insulin-Secreting Cells; Ki-67 Antigen; Male; Postprandial Period; Pyrazines; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; RNA, Messenger; Sitagliptin Phosphate; Triazoles

2012
Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats.
    Drug and chemical toxicology, 2012, Volume: 35, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antifungal Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Creatinine; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Injections, Intraperitoneal; Kidney; Liver; Microscopy, Electron, Transmission; Molecular Structure; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Toxicity Tests; Triazoles; Voriconazole

2012
[Sitagliptin in the treatment of type 2 diabetes: new data presented during the American Diabetes Association annual meeting (San Diego, California, June 2011)].
    Drugs of today (Barcelona, Spain : 1998), 2011, Volume: 47 Suppl D

    Topics: Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Triazoles

2011
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:5

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Hyperinsulinism; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Obese; Phenylalanine; Triazoles

2012
Vestibular toxicity of cis-2-pentenenitrile in the rat.
    Toxicology letters, 2012, Jun-20, Volume: 211, Issue:3

    Topics: Animals; Behavior, Animal; Body Weight; Central Nervous System; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Activation; Epithelium; Fluoresceins; Fluorescent Dyes; Hair Cells, Auditory; Male; Microscopy, Electron, Scanning; Motor Activity; Nitriles; Rats; Rats, Long-Evans; Triazoles; Vestibular Diseases; Vestibule, Labyrinth

2012
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:10

    Topics: Adamantane; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptides; Drinking; Eating; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Immunohistochemistry; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Pyrazines; Sitagliptin Phosphate; Triazoles

2012
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.
    Diabetologia, 2012, Volume: 55, Issue:8

    Topics: Animals; Apolipoproteins E; Arteriosclerosis; Body Weight; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Immunohistochemistry; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Pyrazines; Sitagliptin Phosphate; Triazoles

2012
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Adult; Alanine Transaminase; Blood Glucose; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Inflammation; Liraglutide; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pioglitazone; Platelet Count; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles

2012
Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    European journal of pharmacology, 2013, Jan-05, Volume: 698, Issue:1-3

    Topics: Animals; Blood Pressure; Body Weight; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 4; Heart; Homeostasis; Intracellular Space; Male; Muscle, Skeletal; Myocytes, Cardiac; Phosphorylation; Protein Transport; Pyrazines; Rats; Rats, Inbred SHR; RNA, Messenger; Signal Transduction; Sitagliptin Phosphate; Triazoles; Up-Regulation

2013
Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
    European journal of pharmacology, 2013, Jan-05, Volume: 698, Issue:1-3

    Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Drinking; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Male; Molecular Docking Simulation; Niacinamide; Oxidative Stress; Pancreas; Peptide Fragments; Protein Conformation; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Time Factors; Triazoles; Triterpenes

2013
Influence of ovarian and non-ovarian estrogens on weight gain in response to disruption of sweet taste--calorie relations in female rats.
    Hormones and behavior, 2013, Volume: 63, Issue:1

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Energy Intake; Energy Metabolism; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Saccharin; Sweetening Agents; Taste; Triazoles; Weight Gain

2013
Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary.
    Fertility and sterility, 2013, Mar-01, Volume: 99, Issue:3

    Topics: Animals; Aromatase Inhibitors; Bacterial Proteins; Body Weight; Cell Proliferation; Cells, Cultured; Coculture Techniques; Estrous Cycle; Female; Gene Expression; Granulosa Cells; Hormones; Letrozole; Nitriles; Organ Size; Ovary; Rats; Repressor Proteins; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Theca Cells; Triazoles

2013
Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%.
    Journal of endocrinological investigation, 2013, Volume: 36, Issue:8

    Topics: Aged; Asian People; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles

2013
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
    Pharmacotherapy, 2013, Volume: 33, Issue:3

    Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole

2013
Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.
    Nutritional neuroscience, 2002, Volume: 5, Issue:5

    Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Antidepressive Agents, Second-Generation; Arcuate Nucleus of Hypothalamus; Body Weight; Energy Intake; Immunohistochemistry; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Piperazines; Rats; Rats, Sprague-Dawley; Triazoles

2002
Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 76, Issue:2

    Topics: Animals; Autoradiography; Behavior, Animal; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Electrochemistry; Fungicides, Industrial; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Neurotransmitter Agents; Nucleus Accumbens; Prefrontal Cortex; Receptors, Dopamine D1; Serotonin; Triazoles

2003
Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor.
    The American journal of pathology, 2004, Volume: 164, Issue:3

    Topics: Adrenal Glands; Animals; Aromatase; Body Weight; Cryptorchidism; Disease Models, Animal; Endocrine System Diseases; Estradiol; Gynecomastia; Humans; Immunohistochemistry; Leydig Cells; Male; Mammary Glands, Human; Mice; Mice, Transgenic; Nitriles; Pituitary Gland; Promoter Regions, Genetic; Spermatogenesis; Testosterone; Triazoles; Ubiquitin C

2004
Critically timed ethanol exposure reduces GABAAR function on septal neurons developing in vivo but not in vitro.
    Brain research, 2004, May-15, Volume: 1008, Issue:1

    Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Bicuculline; Body Weight; Cells, Cultured; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Ethanol; Female; GABA Agonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Penicillins; Picrotoxin; Pregnancy; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Septum of Brain; Streptomycin; Time Factors; Triazoles; Up-Regulation; Zinc; Zolpidem

2004
Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
    Brain research, 2004, May-22, Volume: 1008, Issue:2

    Topics: Animals; Behavior, Animal; Benzazepines; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperazines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Serotonin; Triazoles

2004
Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole in an experimental model of colitis in the rat.
    European journal of pharmacology, 2004, Jun-28, Volume: 494, Issue:2-3

    Topics: Animals; Body Weight; Colitis; Colon; Cytokines; Diarrhea; Immunohistochemistry; Immunosuppressive Agents; Male; Neutrophil Infiltration; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Triazoles; Trinitrobenzenesulfonic Acid

2004
The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice.
    The Journal of endocrinology, 2004, Volume: 182, Issue:1

    Topics: Animals; Aromatase; Aromatase Inhibitors; Body Weight; Collagen; Collagen Type II; Collagen Type X; Growth Plate; Immunohistochemistry; Letrozole; Male; Mice; Mice, Inbred ICR; Nitriles; Receptor, IGF Type 1; Sexual Maturation; Tail; Tibia; Triazoles

2004
The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood.
    Toxicology and applied pharmacology, 2004, Oct-01, Volume: 200, Issue:1

    Topics: Animals; Animals, Newborn; Autoradiography; Behavior, Animal; Body Weight; Brain Chemistry; Dose-Response Relationship, Drug; Female; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neuronal Plasticity; Neurotransmitter Agents; Triazoles

2004
The effects of aromatase inhibition on testosterone-dependent conditioned rhythmic cloacal sphincter movements in male Japanese quail.
    Physiology & behavior, 2004, Oct-30, Volume: 83, Issue:1

    Topics: Animals; Aromatase Inhibitors; Body Weight; Cloaca; Conditioning, Operant; Coturnix; Defecation; Enzyme Inhibitors; Female; Male; Movement; Testosterone; Triazoles

2004
Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver.
    Toxicology letters, 2005, Feb-15, Volume: 155, Issue:2

    Topics: Administration, Oral; Animals; Body Weight; Cytochrome P-450 Enzyme System; Fungicides, Industrial; Gene Expression; Liver; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Organ Size; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2005
Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Neurological research, 2005, Volume: 27, Issue:1

    Topics: Adenosine; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Neural Conduction; Phenethylamines; Purinergic P2 Receptor Agonists; Rats; Regional Blood Flow; Sciatic Nerve; Staining and Labeling; Streptozocin; Theophylline; Time Factors; Triazines; Triazoles

2005
The effect of fenbuconazole on cell proliferation and enzyme induction in the liver of female CD1 mice.
    Toxicology and applied pharmacology, 2006, Jul-15, Volume: 214, Issue:2

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Body Weight; Cell Enlargement; Cell Proliferation; Cytochrome P-450 CYP2B1; Cytochrome P450 Family 2; Cytochromes b5; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fungicides, Industrial; Hepatocytes; Liver; Liver Neoplasms; Mice; Nitriles; Organ Size; Phenobarbital; Steroid Hydroxylases; Time Factors; Triazoles

2006
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Bone, 2006, Volume: 39, Issue:4

    Topics: Animals; Aromatase Inhibitors; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Estrogens; Female; Imidazoles; Injections, Intravenous; Letrozole; Nitriles; Organ Size; Osteocalcin; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; Triazoles; Uterus; Zoledronic Acid

2006
Effect of conazole fungicides on reproductive development in the female rat.
    Reproductive toxicology (Elmsford, N.Y.), 2006, Volume: 22, Issue:4

    Topics: Administration, Oral; Animals; Animals, Newborn; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrus; Female; Fungicides, Industrial; Gestational Age; Litter Size; Liver; Male; Molecular Structure; Organ Size; Ovary; Pregnancy; Rats; Rats, Wistar; Reproduction; Sex Ratio; Triazoles; Vagina

2006
Disruption of testosterone homeostasis as a mode of action for the reproductive toxicity of triazole fungicides in the male rat.
    Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 95, Issue:1

    Topics: Anal Canal; Animals; Antifungal Agents; Body Weight; Cell Shape; Dose-Response Relationship, Drug; Eating; Female; Fertility; Fungicides, Industrial; Genitalia, Male; Homeostasis; Liver; Male; Nitriles; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Sexual Maturation; Sperm Motility; Spermatozoa; Testosterone; Time Factors; Triazoles

2007
Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.
    Toxicologic pathology, 2006, Volume: 34, Issue:7

    Topics: Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Cholesterol; Cytochrome P-450 Enzyme System; Diet; Female; Fungicides, Industrial; Lipids; Lipoproteins, HDL; Liver; Liver Neoplasms, Experimental; Male; Mice; Microsomes, Liver; Nitriles; Organ Size; Triazoles

2006
Developmental toxic effects of antifungal flusilazole administered by gavage to mice.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2007, Volume: 80, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Antifungal Agents; Body Weight; Dose-Response Relationship, Drug; Female; Fetus; Male; Mice; Mice, Inbred ICR; Organ Size; Pregnancy; Silanes; Triazoles

2007
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
    Clinical drug investigation, 2007, Volume: 27, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole

2007
Experimental endocrine therapies promote epithelial cytodifferentiation and ciliogenesis in the gerbil female prostate.
    Cell and tissue research, 2007, Volume: 328, Issue:3

    Topics: Animals; Body Weight; Cell Differentiation; Cilia; Epithelial Cells; Female; Gerbillinae; Gonadal Steroid Hormones; Hormone Replacement Therapy; Letrozole; Male; Nitriles; Organ Size; Prostate; Testosterone; Triazoles

2007
A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Endocrinology, 2007, Volume: 148, Issue:8

    Topics: Adipocytes; Androgens; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Letrozole; Magnetic Resonance Imaging; Mesentery; Muscle, Skeletal; Nitriles; Organ Size; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Testosterone; Triazoles

2007
[The role of the ovarian steroid aromatase in pathogenesis of reproductive cycles disorders].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2007, Volume: 53, Issue:1

    Topics: Administration, Oral; Anestrus; Animals; Aromatase; Aromatase Inhibitors; Body Weight; Estrous Cycle; Female; Infertility, Female; Letrozole; Nitriles; Organ Size; Ovary; Rats; Rats, Wistar; Triazoles

2007
Evaluation of neurodevelopmental effects on rats exposed prenatally to sulfentrazone.
    Neurotoxicology, 2007, Volume: 28, Issue:6

    Topics: Animals; Behavior, Animal; Body Weight; Comet Assay; Dose-Response Relationship, Drug; Ear; Eye; Female; Gestational Age; Herbicides; Leukocytes; Locomotion; Male; Maternal Behavior; Motor Skills; Muscle Strength; Mutagens; Nervous System; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reflex; Sulfonamides; Testis; Time Factors; Triazoles

2007
Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:6

    Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles

2007
Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure.
    Pediatric research, 2007, Volume: 62, Issue:5

    Topics: Adenosine; Animals; Animals, Newborn; Apoptosis; Astrocytes; Behavior, Animal; Body Weight; Brain; Caffeine; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Mice; Microtubule-Associated Proteins; Models, Animal; Nerve Growth Factors; Organ Size; Phenethylamines; Pyrimidines; Receptor, Adenosine A2A; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Synaptophysin; Time Factors; Triazoles

2007
A 52-week repeated dose toxicity study of ultraviolet absorber 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats.
    Drug and chemical toxicology, 2008, Volume: 31, Issue:1

    Topics: Administration, Oral; Alkaline Phosphatase; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Erythrocytes; Female; Heart; Liver; Male; No-Observed-Adverse-Effect Level; Organ Size; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Sex Factors; Time Factors; Toxicity Tests, Chronic; Triazoles; Ultraviolet Rays

2008
Preventive effects of letrozole in the model of premenopausal mammary carcinogenesis.
    Neoplasma, 2008, Volume: 55, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Body Weight; Drug Screening Assays, Antitumor; Female; Letrozole; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Nitriles; Rats; Rats, Sprague-Dawley; Triazoles

2008
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:4

    Topics: Adult; Alkynes; Antifungal Agents; Benzoxazines; Body Weight; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Epidemiologic Methods; Humans; Male; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Triazoles; Voriconazole

2008
Lack of gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in preweaning rats.
    Drug and chemical toxicology, 2008, Volume: 31, Issue:2

    Topics: Administration, Oral; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Dose-Response Relationship, Drug; Female; L-Lactate Dehydrogenase; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Serum Albumin; Sex Factors; Triazoles

2008
The effect of 3-amino-1,2,4-triazole on hepatic and renal deiodination of L-thyroxine to 3,5,3'-triiodothyronine.
    Toxicology and applied pharmacology, 1981, Volume: 60, Issue:1

    Topics: Amitrole; Animals; Biotransformation; Body Weight; Kidney; Liver; Male; Organ Size; Rats; Rats, Inbred Strains; Thyroxine; Triazoles; Triiodothyronine

1981
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
    Transplantation proceedings, 1995, Volume: 27, Issue:5

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles

1995
Developmental toxicity of cyproconazole, an inhibitor of fungal ergosterol biosynthesis, in the rat.
    Bulletin of environmental contamination and toxicology, 1995, Volume: 54, Issue:3

    Topics: Abnormalities, Drug-Induced; Analysis of Variance; Animals; Antifungal Agents; Body Weight; Dose-Response Relationship, Drug; Embryo Loss; Embryonic and Fetal Development; Female; Male; Osteogenesis; Pregnancy; Random Allocation; Rats; Rats, Wistar; Teratogens; Triazoles

1995
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
    The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:6

    Topics: Albuminuria; Animals; Azepines; Blood Pressure; Body Weight; Eicosanoids; Inulin; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; p-Aminohippuric Acid; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles

1994
A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1994, Volume: 22, Issue:3

    Topics: Animals; Body Weight; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Eating; Liver; Male; Microsomes, Liver; Organ Size; Oxidoreductases; Rats; Rats, Inbred Strains; Triazoles

1994
Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
    Brain research, 1993, May-07, Volume: 610, Issue:2

    Topics: Animals; Antidepressive Agents; Autoradiography; Biomarkers; Body Weight; Choline O-Acetyltransferase; Conditioning, Operant; Hemicholinium 3; Ibotenic Acid; Immunohistochemistry; Learning; Neuromuscular Depolarizing Agents; Parasympathetic Nervous System; Piperidines; Prosencephalon; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Synaptic Transmission; Triazoles

1993
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
    Pharmaceutical research, 1993, Volume: 10, Issue:8

    Topics: Animals; Body Weight; Cholesterol; Diet; Eating; Feces; Hyperlipidemias; Hypolipidemic Agents; Intestine, Small; Lipid Metabolism; Lipoproteins; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Triazoles; Triglycerides

1993
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
    Endocrinology, 1997, Volume: 138, Issue:6

    Topics: Absorptiometry, Photon; Aging; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Development; Bone Remodeling; Enzyme Inhibitors; Femur; Insulin-Like Growth Factor I; Male; Orchiectomy; Rats; Rats, Wistar; Reference Values; Triazoles

1997
Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists.
    Neuropharmacology, 1997, Volume: 36, Issue:9

    Topics: Animals; Animals, Newborn; Blood Gas Analysis; Blood Glucose; Body Temperature; Body Weight; Brain; Brain Ischemia; Cerebrovascular Circulation; Female; Hypoxia, Brain; Male; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; RNA, Messenger; Theophylline; Triazoles; Xanthines

1997
The weanling male rat as an assay for endocrine disruption: preliminary observations.
    Regulatory toxicology and pharmacology : RTP, 1997, Volume: 26, Issue:3

    Topics: Anastrozole; Androgen Antagonists; Animals; Body Weight; Cyproterone Acetate; Drug Evaluation, Preclinical; Endocrine System Diseases; Female; Lactose; Male; Methylcellulose; Nitriles; Organ Size; Oxazines; Oxazoles; Rats; Rats, Inbred Strains; Toxicology; Triazoles; Uterus; Weaning

1997
Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat.
    The American journal of physiology, 1998, Volume: 274, Issue:2

    Topics: Aging; Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Body Weight; Bone Resorption; Enzyme Inhibitors; Estradiol; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone; Tosyl Compounds; Triazoles

1998
In ovo treatment with an aromatase inhibitor masculinizes postnatal hormone levels, abdominal fat pad content, and GH pulsatility in broiler chickens.
    Domestic animal endocrinology, 1998, Volume: 15, Issue:2

    Topics: Adipose Tissue; Analysis of Variance; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Chick Embryo; Chickens; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Growth Hormone; Injections; Male; Random Allocation; Sex Characteristics; Testosterone; Thyroxine; Time Factors; Triazoles; Triiodothyronine

1998
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Body Height; Body Weight; Breast Neoplasms; Female; Humans; Male; Middle Aged; Population; Regression Analysis; Sex Factors; Triazoles

1998
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Carcinogenesis, 1998, Volume: 19, Issue:8

    Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Carcinogens; Drug Administration Schedule; Drug Screening Assays, Antitumor; Estradiol; Estrus; Female; Genes, ras; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Testosterone; Triazoles

1998
Organizational effects of estrogens on brain vasotocin and sexual behavior in quail.
    Journal of neurobiology, 1998, Volume: 37, Issue:4

    Topics: Analysis of Variance; Animals; Aromatase Inhibitors; Body Weight; Brain Chemistry; Cloaca; Coturnix; Embryo, Nonmammalian; Estradiol; Female; Immunohistochemistry; Male; Neurons; Preoptic Area; Sex Characteristics; Sexual Behavior, Animal; Testosterone; Triazoles; Vasotocin

1998
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.
    Research communications in molecular pathology and pharmacology, 1998, Volume: 102, Issue:1

    Topics: Animals; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Enzyme Inhibitors; Inflammation; Leukocyte Count; Male; Microsomes, Liver; Neutrophils; Nitrates; Nitrites; Organ Size; Rats; Rats, Sprague-Dawley; Survival Analysis; Triazoles; Zymosan

1998
Single day treatment--a feasible tool in revealing not dependent on maternal toxicity teratogenic potential.
    Advances in experimental medicine and biology, 1998, Volume: 444

    Topics: Abnormalities, Drug-Induced; Animals; Benomyl; Body Weight; Female; Plant Growth Regulators; Pregnancy; Rats; Rats, Wistar; Teratogens; Triazoles

1998
Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.
    Bone, 2000, Volume: 27, Issue:5

    Topics: Aging; Animals; Aromatase Inhibitors; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Enzyme Inhibitors; Estradiol; Estrogens; Male; Models, Animal; Rats; Rats, Wistar; Triazoles

2000
Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies.
    Virchows Archiv. B, Cell pathology, 1975, Volume: 17, Issue:4

    Topics: Amitrole; Animals; Aspirin; Body Weight; Carboxylic Acids; Catalase; Citrates; Clofibrate; Cyclopropanes; Esters; Inclusion Bodies; Ketoglutaric Acids; Liver; Methylation; Microbodies; Organ Size; Organoids; Propionates; Rats; Triazoles

1975
Subacute toxicity of ethylenebisisothiocyanate sulfide in the laboratory rat.
    Journal of toxicology and environmental health, 1977, Volume: 2, Issue:5

    Topics: Animals; Body Weight; Dermatitis; Diet; Dose-Response Relationship, Drug; Iodine Radioisotopes; Isothiocyanates; Methimazole; Organ Size; Rats; Thiocyanates; Thyroid Function Tests; Thyroxine; Triazoles; Triiodothyronine

1977
[Toxicological studies on cefatrizine (S 640 P). 1. Acute toxicity, subacute toxicity in rats(author's transl)].
    The Japanese journal of antibiotics, 1976, Volume: 29, Issue:6

    Topics: Acute Disease; Administration, Oral; Animals; Body Weight; Cephalosporins; Dogs; Drug Evaluation, Preclinical; Female; Injections, Intradermal; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Mice; Rabbits; Rats; Triazoles

1976
[Toxicological studies on cefatrizine (S-640 P). 3. Chronic toxicity in rats(author's transl)].
    The Japanese journal of antibiotics, 1976, Volume: 29, Issue:6

    Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Bronchitis; Cephalosporins; Chronic Disease; Drinking; Drug Evaluation, Preclinical; Eating; Female; Lung; Male; Pneumonia; Rats; Triazoles

1976
[Toxicological studies on cefatrizine (S-640 P). 2. Subacute toxicity in rats (author's transl)].
    The Japanese journal of antibiotics, 1976, Volume: 29, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Cephalosporins; Drug Evaluation, Preclinical; Female; Liver; Lung; Male; Pulmonary Atelectasis; Rats; Time Factors; Triazoles

1976
Chronic toxicity and carcinogenicity studies with FWAs.
    Environmental quality and safety. Supplement, 1975, Volume: 4

    Topics: Aging; Animals; Biphenyl Compounds; Body Weight; Carcinogens; Coloring Agents; Diet; Dogs; Female; Male; Organ Size; Rats; Species Specificity; Stilbenes; Triazoles

1975
Three-generation Reproduction studies with FWAs.
    Environmental quality and safety. Supplement, 1975, Volume: 4

    Topics: Animals; Behavior, Animal; Biphenyl Compounds; Body Weight; Coloring Agents; Female; Male; Mice; Organ Size; Reproduction; Sexual Behavior, Animal; Stilbenes; Triazoles

1975
Dapiprazol prevents U50,488H-mediated suppression of preparatory components of drinking behavior in rats.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Animals; Body Weight; Depression, Chemical; Diuresis; Drinking Behavior; Male; Naloxone; Piperazines; Pyrrolidines; Rats; Rats, Inbred Strains; Triazoles

1991
Endocrine and antitumoral effects of R76713 in rats.
    Journal of enzyme inhibition, 1990, Volume: 4, Issue:2

    Topics: Adrenal Cortex Hormones; Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Ovary; Progesterone; Rats; Rats, Inbred Strains; Triazoles; Uterus

1990
A new non-hormonal antifertility drug DL 111-IT: I. Effects on testes and accessory glands of reproduction in male rats.
    Contraception, 1986, Volume: 33, Issue:1

    Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Animals; Body Weight; DNA; Epididymis; Genitalia, Male; Male; Organ Size; Prostate; Proteins; Rats; Rats, Inbred Strains; RNA; Seminal Vesicles; Sexual Maturation; Testis; Triazoles

1986
[5-Substituted 3-mercapto-4H-1,2,4-triazoles as a potential thyrostaticagent].
    Ceskoslovenska farmacie, 1989, Volume: 38, Issue:8

    Topics: Animals; Body Weight; Male; Organ Size; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thyroid Gland; Thyroxine; Triazoles

1989
Inhibition by 3-amino-1H-1,2,4-triazole of hepatic tumorigenesis induced by diethylstilbestrol alone or combined with N-nitrosobutylurea in WF rats.
    Journal of the National Cancer Institute, 1985, Volume: 74, Issue:6

    Topics: Amitrole; Animals; Body Weight; Diethylstilbestrol; Liver Neoplasms; Male; Nitrosourea Compounds; Organ Size; Oxidation-Reduction; Pituitary Neoplasms; Rats; Rats, Inbred WF; Thyroid Gland; Triazoles

1985
Effect of aminotriazole on thyroid function in the rat.
    Toxicology and applied pharmacology, 1968, Volume: 13, Issue:3

    Topics: Amines; Animals; Body Weight; Iodine Radioisotopes; Male; Rats; Thyroid Function Tests; Thyroid Gland; Triazoles

1968
Studies on regulatory aspects of nutrition at molecular level. I. Enzyme turnover during fasting.
    Archives internationales de physiologie et de biochimie, 1968, Volume: 76, Issue:4

    Topics: Animals; Body Weight; Catalase; Depression, Chemical; Fasting; Kidney; Kinetics; Liver; Male; Nutritional Physiological Phenomena; Organ Size; Rats; Spectrophotometry; Starvation; Time Factors; Triazoles

1968
Fetal uptake and embryogenetic effects of aminotriazole in mice.
    Archives of toxicology, 1974, Volume: 33, Issue:1

    Topics: Administration, Oral; Amitrole; Animals; Autoradiography; Body Weight; Bone Marrow; Carbon Radioisotopes; Chromatography, Thin Layer; Female; Fertility; Fetus; Gastric Mucosa; Gestational Age; Injections, Intravenous; Maternal-Fetal Exchange; Mice; Pregnancy; Spleen; Teratogens; Thymus Gland; Triazoles

1974
Effect of carbon monoxide or of 3-aminotriazole on C-and N-hydroxylation of the carcinogen N-2-fluorenylacetamide by liver microsomes of hamsters pretreated with 3-methylcholanthrene.
    Xenobiotica; the fate of foreign compounds in biological systems, 1972, Volume: 2, Issue:5

    Topics: Acetamides; Animals; Body Weight; Carbon Isotopes; Carbon Monoxide; Carcinogens; Chromatography, Paper; Cricetinae; Cytochrome P-450 Enzyme System; Fluorenes; Herbicides; Hydroxylation; Liver; Male; Methylcholanthrene; Microsomes, Liver; Organ Size; Triazoles

1972
The toxicity of amitrole in the rat.
    Toxicology and applied pharmacology, 1973, Volume: 26, Issue:1

    Topics: Amitrole; Animals; Body Weight; Diet; Female; Herbicides; Hyperplasia; Intubation, Gastrointestinal; Kidney; Liver; Male; Microscopy, Electron; Organ Size; Pyelonephritis; Rats; Reproduction; Sex Factors; Skin Diseases; Spleen; Thyroid Gland; Triazoles

1973
The effect of ethyl-alpha-p-chlorophenoxisobutyrate (clofibrate) on alcohol metabolism.
    Life sciences, 1973, Oct-01, Volume: 13, Issue:7

    Topics: Administration, Oral; Alcohol Oxidoreductases; Animals; Body Weight; Carbon Radioisotopes; Catalase; Clofibrate; Dinitrophenols; Ethanol; Female; In Vitro Techniques; Kinetics; Liver; Methanol; Microsomes, Liver; Organ Size; Oxidation-Reduction; Pyrazoles; Rats; Time Factors; Triazoles

1973
Triamiphos: long-term toxicity and three-generation reproduction studies in rats.
    Toxicology, 1974, Volume: 2, Issue:4

    Topics: Animals; Blood Cell Count; Body Weight; Brain; Cholinesterase Inhibitors; Cholinesterases; Dimethylamines; Eating; Erythrocytes; Female; Fertility; Germ-Free Life; Growth; Hemoglobins; Insecticides; Male; Neoplasms; Organ Size; Organophosphorus Compounds; Rats; Reproduction; Time Factors; Triazoles

1974
Effect of reduced food intake on thyroid cell height and goitrogenic response in rats.
    The Journal of endocrinology, 1971, Volume: 49, Issue:1

    Topics: Animals; Body Weight; Drinking Behavior; Epithelial Cells; Food Deprivation; Goiter; Iodine Isotopes; Male; Organ Size; Rats; Thyroid Gland; Thyroid Hormones; Thyrotropin-Releasing Hormone; Triazoles

1971
Carcinogen-mediated alteration of the rates of enzyme synthesis and degradation.
    Enzymologia biologica et clinica, 1968, Volume: 9, Issue:4

    Topics: Animals; Body Weight; Carcinogens; Catalase; Kidney; Kinetics; Liver; Male; Rats; Triazoles

1968
Studies on regulatory aspects of nutriton at molecular level. II. Enzyme turnover during protein deficiency.
    Nutritio et dieta; European review of nutrition and dietetics, 1969, Volume: 11, Issue:3

    Topics: Amides; Animals; Body Weight; Caseins; Catalase; Depression, Chemical; Diet; Kidney; Kinetics; Liver; Male; Mathematics; Molecular Biology; Nutritional Physiological Phenomena; Organ Size; Protein Deficiency; Time Factors; Triazoles

1969
Aminotriazole, thyroid function, and catecholamines in nephrogenic hypertension in rats.
    Canadian journal of physiology and pharmacology, 1969, Volume: 47, Issue:5

    Topics: Adrenal Glands; Animals; Blood Pressure; Body Temperature; Body Weight; Epinephrine; Heart Rate; Hypertension, Renal; Hypothyroidism; Iodine; Male; Myocardium; Norepinephrine; Organ Size; Oxygen Consumption; Rats; Thyroid Gland; Triazoles

1969